Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,070 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Central sympatholytics prolong survival in experimental sepsis.
Hofer S, Steppan J, Wagner T, Funke B, Lichtenstern C, Martin E, Graf BM, Bierhaus A, Weigand MA. Hofer S, et al. Crit Care. 2009;13(1):R11. doi: 10.1186/cc7709. Epub 2009 Feb 6. Crit Care. 2009. PMID: 19196475 Free PMC article.
Pharmacologic cholinesterase inhibition improves survival in experimental sepsis.
Hofer S, Eisenbach C, Lukic IK, Schneider L, Bode K, Brueckmann M, Mautner S, Wente MN, Encke J, Werner J, Dalpke AH, Stremmel W, Nawroth PP, Martin E, Krammer PH, Bierhaus A, Weigand MA. Hofer S, et al. Crit Care Med. 2008 Feb;36(2):404-8. doi: 10.1097/01.CCM.0B013E31816208B3. Crit Care Med. 2008. PMID: 18091537
Thioredoxin in human and experimental sepsis.
Hofer S, Rosenhagen C, Nakamura H, Yodoi J, Bopp C, Zimmermann JB, Goebel M, Schemmer P, Hoffmann K, Schulze-Osthoff K, Breitkreutz R, Weigand MA. Hofer S, et al. Crit Care Med. 2009 Jul;37(7):2155-9. doi: 10.1097/CCM.0b013e31819fff67. Crit Care Med. 2009. PMID: 19487947
Hemofiltration and immune response in severe sepsis.
Hörner C, Schuster S, Plachky J, Hofer S, Martin E, Weigand MA. Hörner C, et al. Among authors: hofer s. J Surg Res. 2007 Sep;142(1):59-65. doi: 10.1016/j.jss.2006.09.019. J Surg Res. 2007. PMID: 17716608 Clinical Trial.
The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation.
Kayhan N, Funke B, Conzelmann LO, Winkler H, Hofer S, Steppan J, Schmidt H, Bardenheuer H, Vahl CF, Weigand MA. Kayhan N, et al. Among authors: hofer s. Crit Care. 2008;12(5):R125. doi: 10.1186/cc7033. Epub 2008 Oct 13. Crit Care. 2008. PMID: 18847498 Free PMC article.
1,070 results